Alere provides diagnostics and health management solutions. The Company's products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women's health. Its brands range from over-the-counter tests to lab-based diagnostics to integrated home monitoring solutions. Alere's brands include Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, BinaxNOW, Cholestech LDX, Clearview iFOB Complete, Determine HBsAg, DoubleCheckGold and ImmunoComb.
Type
Public
HQ
Waltham, US
Founded
1981
Size (employees)
9,700 (est)
Website
alere.com
Alere was founded in 1981 and is headquartered in Waltham, US
Report incorrect company information

Alere Office Locations

Alere has an office in Waltham
Waltham, US (HQ)
200 51 Sawyer Rd
Show all (1)
Report incorrect company information

Alere Financials and Metrics

Alere Financials

Alere's revenue was reported to be $582.28 m in FY, 2016 which is a 76.4% decrease from the previous period.
USD

Revenue (Q2, 2017)

557.7 m

Net income (Q2, 2017)

(92.7 m)

EBIT (Q2, 2017)

(29 m)

Market capitalization (2-Oct-2017)

4.5 b

Cash (30-Jun-2017)

491.7 m

EV

6.8 b
Alere's current market capitalization is $4.5 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

3 b2.6 b2.5 b582.3 m

Revenue growth, %

(15%)(5%)(76%)

Sales and marketing expense

102 m

General and administrative expense

148.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

753.9 m716.6 m737.9 m736.2 m608.2 m629.2 m602 m578.2 m611.1 m582.4 m588.2 m557.7 m

Sales and marketing expense

159.6 m147.1 m150.7 m136.3 m109.1 m107.2 m106.5 m99.8 m102.5 m102 m94.2 m96.2 m

General and administrative expense

142.4 m139.5 m159.9 m130.2 m92.7 m60.8 m101.3 m115 m128.4 m129.3 m166.3 m156 m

R&D expense

40.5 m38.7 m37.4 m38.7 m28 m27.2 m36 m27.1 m28.4 m31.4 m26.3 m29.4 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

361.9 m378.5 m502.2 m567.2 m

Accounts Receivable

Inventories

129.7 m131.6 m152.2 m308.9 m

Current Assets

1.5 b1.8 b1.5 b1.5 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

354 m433 m464.9 m479.4 m490.7 m506.2 m566.2 m601.5 m491.7 m

Inventories

370.4 m371.1 m366.3 m362.2 m350.9 m333.8 m348.8 m322.5 m335.7 m

Current Assets

1.5 b1.5 b1.9 b1.9 b1.5 b1.4 b1.5 b1.5 b1.4 b

PP&E

544.3 m545.1 m448.3 m445.3 m445.2 m438.8 m446.3 m439.8 m436.2 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(70.3 m)9.9 m206.8 m(137.3 m)

Depreciation and Amortization

439.4 m335.8 m309.3 m285.6 m

Inventories

(12 m)(48 m)(43 m)

Accounts Payable

13 m47.9 m(10.8 m)4.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(67 m)(6.1 m)(55.7 m)(142.2 m)209.2 m229.5 m235 m(10 m)(44.9 m)(22.8 m)(64.1 m)(92.7 m)

Depreciation and Amortization

326.7 m98.1 m196 m290.8 m74.4 m147 m233.5 m72.5 m142.4 m214.2 m60.9 m62.5 m

Accounts Payable

16 m5.2 m30.8 m38.3 m(18.6 m)(23.3 m)(16 m)(31.5 m)(1 k)18.5 m13.4 m

Cash From Operating Activities

159.1 m105.9 m125.2 m216.9 m28.4 m32.5 m137.3 m(4.6 m)94.1 m147 m61.1 m
USDY, 2017

EV/EBIT

-233.8 x

Revenue/Employee

57.5 k

Financial Leverage

3.1 x
Show all financial metrics
Report incorrect company information

Alere Online and Social Media Presence

Embed Graph
Report incorrect company information

Alere News and Updates

The Global Influenza Market

LONDON, June 13, 2018 /PRNewswire/ -- Report Scope:This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is global, with emphasis on U.S....

Cholesterol Testing Kits Market 2018 – Size, Status, Growth, Shares, Trends, Analysis, and Forecast Reports 2026

Rise in lifestyle changes has led to growing prevalence of obesity, cardiovascular diseases and diabetes, which primarily drive the cholesterol testing kits market. As per statistics presented by Renew Bariatrics, Inc., around 775 million were reported to suffer from obesity across the globe in 2017…

Lyme Disease Diagnostics Market – Growth, Future Prospects and Competitive Analysis, 2018 - 2026 - Credence Research

According to the American Lyme Disease Foundation, Lyme disease occurs due to the bite of deer tick which through its bite transmits the infection of Borrelia burgdoferi a type of spirochete bacterium. The bacterium travels through the bloodstream and settles in various body tissues. The clinical ma…

Hemostasis Diagnostics Market: Advancements in Hemostasis Technology Lead to Development of Wide Range of Products

Hemostasis Diagnostics Market report categorizes the global market by Product (Laboratory Systems, Consumables & Point-of-Care Testing Systems), Test (Prothrombin Test Time, Platelet Aggregation Test & D Dime), End Users & Geography Posted via Industry Today. Follow us on Twitter @Indus…

UPDATE 2-Abbott's Alere resolves U.S. diagnostic device probe for $33.2 mln

BOSTON, March 23 (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.

UPDATE 1-Abbott's Alere resolves U.S. diagnostic device probe for $33.2 mln

BOSTON, March 23 (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.
Show more
Report incorrect company information